More articles from Commentary

You have access
Risk-Based Selection of Environmental Classifications for Biopharmaceutical Operations
Nick Bevan, Tim Corbidge, David Estape, Lars Hovmand Lyster and Jorgen Magnus

PDA Journal of Pharmaceutical Science and Technology December 2020, pdajpst.2019.010660; DOI: https://doi.org/10.5731/pdajpst.2019.010660
You have access
An Analytical Strategy Based on Multiple Complementary and Orthogonal Chromatographic and Detection Methods (Multidetector Approach) to Effectively Manage the Analytical Evaluation Threshold (AET)
Mark A Jordi and Ted Heise

PDA Journal of Pharmaceutical Science and Technology November 2020, pdajpst.2020.012047; DOI: https://doi.org/10.5731/pdajpst.2020.012047
You have access
Probable Scenarios of Process Contamination with Cutibacterium (Propionibacterium) acnes in Mammalian Cell Bioreactor
Angel L. Salaman-Byron

PDA Journal of Pharmaceutical Science and Technology September 2020, 74 (5) 592-601; DOI: https://doi.org/10.5731/pdajpst.2019.010710
You have access
Compendial Methods: Suitability Verification, Challenges and Recommendations for Proteins
Wen-Li Chung, Jian Yin, Steven Messick, Miguel Saggu, Kate Tschudi, Ann Woys, Rod Rahimi, Marianne Azarias, Connie Kong and Bruce Kabakoff

PDA Journal of Pharmaceutical Science and Technology September 2020, 74 (5) 581-591; DOI: https://doi.org/10.5731/pdajpst.2019.010652
You have access
Steam Sterilization Chemical Indicators Are Not Adequate for Monitoring Real Steam Sterilization Cycles
Paulo Roberto Laranjeira, Rafael Queiroz de Souza, Jeane Aparecida Gonzales Bronzatti and Kazuko Uchigawa Graziano

PDA Journal of Pharmaceutical Science and Technology July 2020, 74 (4) 435-438; DOI: https://doi.org/10.5731/pdajpst.2019.009886
You have access
Continuous and Effective Microbiological Air Monitoring in Critical Environments: A Comparison of Analytical Methodologies
Gilberto Dalmaso, Anna Campanella and Paola Lazzeri

PDA Journal of Pharmaceutical Science and Technology July 2020, 74 (4) 446-455; DOI: https://doi.org/10.5731/pdajpst.2019.010181
You have access
Industry One-Voice-of-Quality (1VQ) Solutions: Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS)—through Enhanced Science and Risk-Based Approaches
Emma Ramnarine, Anders Vinther, Kimberly Bruhin, Christina Tovar and Marcello Colao

PDA Journal of Pharmaceutical Science and Technology July 2020, 74 (4) 456-467; DOI: https://doi.org/10.5731/pdajpst.2020.011734
You have access
The Goldilocks Challenge—Controlling Uncertainty When Setting Product Specifications
Richard K. Burdick and Julia C. O'Neill

PDA Journal of Pharmaceutical Science and Technology July 2020, 74 (4) 439-445; DOI: https://doi.org/10.5731/pdajpst.2019.010850
You have access
Correcting the Analytical Evaluation Threshold (AET) and Reported Extractable's Concentrations for Analytical Response Factor Uncertainty Associated with Chromatographic Screening for Extractables/Leachables
Dennis Jenke

PDA Journal of Pharmaceutical Science and Technology May 2020, 74 (3) 348-358; DOI: https://doi.org/10.5731/pdajpst.2019.010520
You have access
Visible Particulate Contamination Control for Injectable Products: A Life-Cycle Approach
Stephen E. Langille

PDA Journal of Pharmaceutical Science and Technology May 2020, 74 (3) 359-366; DOI: https://doi.org/10.5731/pdajpst.2019.010462

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.